Novel ADAM-17 Inhibitor ZLDI-8 Enhances the in Vitro and in Vivo Chemotherapeutic Effects of Sorafenib on Hepatocellular Carcinoma Cells

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-018-0804-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cytotoxicity of Sorafenib in Human Hepatocellular Carcinoma Cells

Al-Azhar Journal of Pharmaceutical Sciences
2015English

In Vivo Inhibitory Effect of Suberoylanilide Hydroxamic Acid Combined With Sorafenib on Human Hepatocellular Carcinoma Cells

Brazilian Journal of Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2020English

Aspirin Enhances Doxorubicin-Induced Apoptosis and Reduces Tumor Growth in Human Hepatocellular Carcinoma Cells in Vitro and in Vivo

International Journal of Oncology
Cancer ResearchOncology
2012English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

Capsaicin Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma Cells and Mouse Xenograft Tumors Through Increased ERK Signaling

Acta Pharmacologica Sinica
MedicinePharmacology
2017English

Triclosan Treatment Decreased the Antitumor Effect of Sorafenib on Hepatocellular Carcinoma Cells

OncoTargets and Therapy
OncologyPharmacology
2018English

Protein Disulfide Isomerase Inhibition Synergistically Enhances the Efficacy of Sorafenib for Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2017English

The PI3K Inhibitor Copanlisib Synergizes With Sorafenib to Induce Cell Death in Hepatocellular Carcinoma

Cell Death Discovery
Cancer ResearchMolecular NeuroscienceImmunologyCell BiologyCellular
2019English

Antitumor Effect of Sorafenib and mTOR Inhibitor in Liver Transplantation Recipients With Hepatocellular Carcinoma Recurrence

Liver Transplantation
HepatologyTransplantationSurgery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy